C07D 261/18
Carbon atoms having three bonds to hetero atoms, with at the most
Official title: Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
C07D261/18 (Carbon atoms having three bonds to hetero atoms, with at the most) appears on 609 US grants and 598 published applications in this corpus.
Search patents in C07D- Granted patents
- 609
- Published applications
- 598
- Assignees
- 321
- Inventors
- 1,999
- Latest grant
- 13 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 10 | 0 |
| 1978 | 10 | 0 |
| 1979 | 9 | 0 |
| 1980 | 6 | 0 |
| 1981 | 7 | 0 |
| 1982 | 6 | 0 |
| 1983 | 3 | 0 |
| 1984 | 3 | 0 |
| 1985 | 1 | 0 |
| 1986 | 4 | 0 |
| 1987 | 3 | 0 |
| 1988 | 6 | 0 |
| 1989 | 2 | 0 |
| 1990 | 4 | 0 |
| 1991 | 8 | 0 |
| 1992 | 2 | 0 |
| 1993 | 12 | 0 |
| 1994 | 9 | 0 |
| 1995 | 7 | 0 |
| 1996 | 10 | 0 |
| 1997 | 6 | 0 |
| 1998 | 9 | 0 |
| 1999 | 12 | 0 |
| 2000 | 13 | 0 |
| 2001 | 23 | 2 |
| 2002 | 16 | 15 |
| 2003 | 9 | 26 |
| 2004 | 20 | 38 |
| 2005 | 14 | 33 |
| 2006 | 19 | 27 |
| 2007 | 17 | 28 |
| 2008 | 16 | 32 |
| 2009 | 12 | 28 |
| 2010 | 30 | 38 |
| 2011 | 17 | 23 |
| 2012 | 24 | 29 |
| 2013 | 28 | 30 |
| 2014 | 26 | 22 |
| 2015 | 26 | 25 |
| 2016 | 18 | 21 |
| 2017 | 23 | 29 |
| 2018 | 17 | 23 |
| 2019 | 18 | 18 |
| 2020 | 15 | 20 |
| 2021 | 14 | 22 |
| 2022 | 12 | 20 |
| 2023 | 14 | 10 |
| 2024 | 7 | 20 |
| 2025 | 8 | 12 |
| 2026 | 1 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Isoxazole hydroxamic acids as histone deacetylase 6 inhibitors13 Jan 2026US 12,522,572 B2The Board of Trustees of the University of Illinois
- Lysophosphatidic acid receptor antagonist and preparation method therefor5 Aug 2025US 12,377,083 B2Wuhan Ll Science and Technology Development Co., Ltd.
- Compounds, compositions and methods15 Jul 2025US 12,358,928 B2Denali Therapeutics Inc.
- Crystalline (2S,4R)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof8 Jul 2025US 12,351,561 B2Theravance Biopharma R&D IP, LLC
- HBV inhibitor and its use17 Jun 2025US 12,329,741 B2Xi'an Xintong Pharmaceutical Research Co., Ltd.
- Lipid compound and composition for delivery of active substance2 Jul 2026US 2026/0184669 A1Korea Research Institute of Bioscience and Biotechnology
- Novel Processes for Preparation of Soluble Guanylate Cyclase Stimulators18 Jun 2026US 2026/0167634 A1Cyclerion Therapeutics, Inc.
- Amido heteroaromatic compounds11 Jun 2026US 2026/0159508 A1AstraZeneca AB
- Isoxazole hydroxamic acids as histone deacetylase 6 inhibitors30 Apr 2026US 2026/0116861 A1The Board of Trustees of the University of Illinois
- Modulators of mas-related g-protein receptor x4 and related products and methods23 Apr 2026US 2026/0108482 A1Escient Pharmaceuticals, Inc.
Most cited
By later US patents
- Cell differentiation inducer110US 6,174,905 B1Mitsui Chemicals, Inc. · 2001
- Substituted isoxazoles for the treatment of inflammation102US 5,633,272 A1997
- Phenyl-isoxazoles as factor XA Inhibitors100US 6,187,797 B1DuPont Pharmaceuticals Company · 2001
- Novel oxime ethers, the preparation thereof, compositions containing them and the use thereof85US 4,566,901 ACiba-Geigy Corporation · 1986
- 7-substituted tetracycline compounds84US 6,818,635 B2Paratek Pharmaceuticals, Inc. · 2004